|
Sign In to gain access to subscriptions and/or personal tools.
|
Can the FMR1 (Fragile X) Gene Serve As Predictor of Response to Ovarian Stimulation?
Norbert Gleicher, MD*,
Andrea Weghofer, MD, PhD,
Kutluk Oktay, MD,
and
David Barad, MD, MS
* To whom correspondence should be addressed. E-mail: ykizawa{at}thechr.com.
 |
Abstract |
|---|
Because triple CGG repeats on FMR1 correlate with anti-Müllerian hormone, repeats may also correlate with clinical outcomes. In 55 in vitro fertilization patients, repeats, corrected for gonadotropin dosage, were, therefore, correlated to oocytes. Patients were stratified by <35 and 35 repeats, and by age to <38 or 38 years. Less than 35 (but not 35) repeats demonstrated significantly lower anti-Müllerian hormone at ages 38 than at <38 years (P < .05). In >38 years, anti-Müllerian hormone was not affected by repeats. In <38 years, with <35 repeats (though not with 35), required significantly less gonadotropins than 38 (P < .05). In <38 years (though not 38), those with <35 repeats produced significantly more oocytes than women with 35 repeats (P = .006). In <38 years, retrieved oocytes were inversely related to repeats, adjusted for gonadotropin dosage (P = .03). This supports FMR1 testing as useful in fertility practice and suggests why response rates to increasing stimulation with gonadotropins may vary.
First published on December 30, 2008, doi:10.1177/1933719108328617
Reproductive Sciences 2009;16:462.
A more recent version of this article appeared on May 1, 2009

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|